QL Block in Laparoscopic Myomectomy for Postoperative Pain

This study is looking at whether an injection called a QL block can help reduce pain after laparoscopic myomectomy surgery for uterine fibroids. A QL block involves injecting Bupivacaine (a numbing medicine) into a muscle in your lower back. Some participants will receive Bupivacaine, while others will receive Saline (saltwater) as a comparison. Researchers want to see if the QL block helps you need less pain medicine and delays when you first ask for pain relief within 24 hours after surgery. You may be able to join if you are a woman between 18 and 45 years old, have uterine fibroids requiring surgery, and are willing to follow study procedures. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 80 women. Participants will receive either Bupivacaine or Saline injections.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Researchers will track your need for pain medicine for up to 24 hours after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05979493

QL Block in Laparoscopic Myomectomy

Recruiting
PHASE4Ages 18–45InterventionalSupportive care
Joseph Findley MD
~80 participants
Updated 2026-09-11 on ClinicalTrials.gov
What's tested:BupivacainSaline

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Time in minutes from first analgesic request as measured by medical chart review
Measured over Up to 24 hours
+1 more outcome measured
Postoperative Pain
Fibroid Uterus

NCT05979493

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University Hospitals Ahuja Medical Center

    Beachwood, Ohiostudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Joseph Findley, MD · PRINCIPAL_INVESTIGATOR · University Hospitals

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Presence of uterine fibroids requiring surgical excision with preservation of the uterus
Stated willingness to comply with all study procedures and availability for the duration of the study
Provision of signed and dated informed consent form

Exclusion

Pre-existing diagnoses of anxiety or depression
Pre-existing coagulopathies
Pre-existing neuropathic or chronic pelvic pain
Chronic opioid use
Illiteracy due to inability to read and understand plain questionnaire
Non-English speaking
BMI \>38
  • Time in minutes from first analgesic request as measured by medical chart reviewUp to 24 hours
  • Total number of doses of rescue analgesics given as measured by medical chart reviewUp to 24 hours